Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abbott signs paclitaxel agreement with NaPro BioTherapeutics

July 29, 1999

Novel epipodophyllotoxin derivatives with excellent antitumor activity

July 28, 1999

Asmarine A and B: novel cytotoxic alkaloids produced by marine organism

July 28, 1999

Kinetek initiates development of ILK and PKB inhibitors for cancer therapy

July 28, 1999

Bayer presents new anticancer compounds that inhibit Raf kinase

July 27, 1999

Paxene approved for E.U. marketing; Paxoral shows positive results in phase I

July 26, 1999

Valentis initiates phase I/II trial of IL-12 gene therapy

July 26, 1999

Extremely potent cytotoxic cryptophycin analogue discovered at Lilly

July 23, 1999

CDK2-inhibitory purine derivatives with potential in cancer therapy

July 23, 1999

UBCLE: a new protein discovered at Incyte; antagonists useful for cancer, etc.

July 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...